Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Peter Hartung

Showing results (151-160 of 601) with videos related to

Pageof 61
Sort By:
Nature Reviews. Drug Discovery|June 6, 2022
Thinking outside the box: non-canonical targets in multiple sclerosisLaura Bierhansl, Hans-Peter Hartung, Orhan Aktas, et al.
Experimental Neurology|June 29, 2007
Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALSHans-Jörg Habisch, Birgit Schwalenstöcker, Ruth Danzeisen, et al.
Brain : a Journal of Neurology|July 26, 2020
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural historyPer Soelberg Sorensen, Finn Sellebjerg, Hans-Peter Hartung, et al.
Glia|July 8, 2015
Macrophage-derived osteopontin induces reactive astrocyte polarization and promotes re-establishment of the blood brain barrier after ischemic strokeMichael Gliem, Kristina Krammes, Lucy Liaw, et al.
Journal of Neurology|March 15, 2019
Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patientsMarkus Kraemer, Jan Claudius Schwitalla, Frank Diesner, et al.
Journal of Neuroimmunology|September 29, 2009
Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosisAmer Awad, Bernhard Hemmer, Hans-Peter Hartung, et al.
Current Opinion in Neurology|April 2, 2016
Recent achievements in stem cell-mediated myelin repairJanusz Joachim Jadasz, Catherine Lubetzki, Bernard Zalc, et al.
Nature Reviews. Neurology|September 16, 2017
CIDP and other inflammatory neuropathies in diabetes - diagnosis and managementYusuf A Rajabally, Mark Stettner, Bernd C Kieseier, et al.
Glia|May 6, 2003
ADAM-10 and ADAM-17 in the inflamed human CNSBernd C Kieseier, Heidrun Pischel, Eva Neuen-Jacob, et al.
Archives of Neurology|July 13, 2006
Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disordersHelmar C Lehmann, Hans-Peter Hartung, Gerd R Hetzel, et al.
Pageof 61

Showing results (151-160 of 601) with videos related to

Sort By:
Pageof 61
Nature Reviews. Drug Discovery|June 6, 2022
Thinking outside the box: non-canonical targets in multiple sclerosisLaura Bierhansl, Hans-Peter Hartung, Orhan Aktas, et al.
Experimental Neurology|June 29, 2007
Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALSHans-Jörg Habisch, Birgit Schwalenstöcker, Ruth Danzeisen, et al.
Brain : a Journal of Neurology|July 26, 2020
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural historyPer Soelberg Sorensen, Finn Sellebjerg, Hans-Peter Hartung, et al.
Glia|July 8, 2015
Macrophage-derived osteopontin induces reactive astrocyte polarization and promotes re-establishment of the blood brain barrier after ischemic strokeMichael Gliem, Kristina Krammes, Lucy Liaw, et al.
Journal of Neurology|March 15, 2019
Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patientsMarkus Kraemer, Jan Claudius Schwitalla, Frank Diesner, et al.
Journal of Neuroimmunology|September 29, 2009
Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosisAmer Awad, Bernhard Hemmer, Hans-Peter Hartung, et al.
Current Opinion in Neurology|April 2, 2016
Recent achievements in stem cell-mediated myelin repairJanusz Joachim Jadasz, Catherine Lubetzki, Bernard Zalc, et al.
Nature Reviews. Neurology|September 16, 2017
CIDP and other inflammatory neuropathies in diabetes - diagnosis and managementYusuf A Rajabally, Mark Stettner, Bernd C Kieseier, et al.
Glia|May 6, 2003
ADAM-10 and ADAM-17 in the inflamed human CNSBernd C Kieseier, Heidrun Pischel, Eva Neuen-Jacob, et al.
Archives of Neurology|July 13, 2006
Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disordersHelmar C Lehmann, Hans-Peter Hartung, Gerd R Hetzel, et al.
Pageof 61